A potential antifungal bioproduct for Microsporum canis: Bee venom
Onderstepoort Journal of Veterinary Research · 2024
DOI: 10.4102/ojvr.v91i1.2191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Onderstepoort Journal of Veterinary Research, 2024. Verfasst von Armağan E Ütük und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Ceyhan Veterinary Faculty, Cukurova University, Adana, Türkiye; and Department of Biotechnology, Institute of Natural and…. Hauptthemen laut MEDLINE: Microsporum, Antifungal Agents, Bee Venoms, Microbial Sensitivity Tests. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Natural treatment options for Microsporum canis dermatophytosis are being explored because of resistance to several antifungal medications. In this study, the potential antifungal effect of bee venom (BV), a natural antimicrobial agent, on M. canis was investigated. The antifungal effects of BV, fluconazole, itraconazole, amphotericin B and terbinafine were evaluated by the macrodilution method at various concentrations by modifying the microdilution method recommended by the European Committee on Antimicrobial Susceptibility Testing. All isolates were observed to be susceptible to terbinafine and fully resistant to fluconazole and amphotericin B. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) values of M. canis isolate 2 (Mc2) were determined as 8 µg/mL for itraconazole. The MIC and MFC values of BV were found to be 320 µg/mL for the Mc2 isolate and 640 µg/mL for the Mc6 isolate. The results showed that the isolates obtained from clinical samples in this study were highly resistant to all antifungal agents, except terbinafine. The increase in resistance indicates that antifungal drugs will become insufficient and ineffective over time and natural products such as BV should be evaluated as alternatives.Contribution: Although there are many drugs for the treatment of M. canis, the increase in resistance to antifungal agents reveals the need for the identification and development of new natural agents. Bee venom, which has been shown to have a safe and weak allergenic effect in various studies, can be tested for usability as a local antifungal drug when supported by in vivo studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Parasitology, Ceyhan Veterinary Faculty, Cukurova University, Adana, Türkiye; and Department of Biotechnology, Institute of Natural and Applied Sciences, Cukurova University, Adana. autuk@cu.edu.tr.
Zitieren
APA
Ütük, A. E., Güven Gökmen, T., Yazgan, H., Eşki, F., Turut, N., Karahan, Ş., Kıvrak, İ., Sevin, S., & Sezer, O. (2024). A potential antifungal bioproduct for Microsporum canis: Bee venom. Onderstepoort Journal of Veterinary Research. https://doi.org/10.4102/ojvr.v91i1.2191
Vancouver
Ütük AE, Güven Gökmen T, Yazgan H, Eşki F, Turut N, Karahan Ş, et al. A potential antifungal bioproduct for Microsporum canis: Bee venom. Onderstepoort Journal of Veterinary Research. 2024. doi:10.4102/ojvr.v91i1.2191
BibTeX
@article{tk2024,
author = {Ütük, Armağan E and Güven Gökmen, Tülin and Yazgan, Hatice and Eşki, Funda and Turut, Nevin and Karahan, Şifa and Kıvrak, İbrahim and Sevin, Sedat and Sezer, Osman},
title = {A potential antifungal bioproduct for Microsporum canis: Bee venom},
journal = {Onderstepoort Journal of Veterinary Research},
year = {2024},
doi = {10.4102/ojvr.v91i1.2191}
}
EUVIMED